Research Articles | Page 13 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Consensus Recommendations for Severe Aplastic Anemia Aug 2024 Blood Advances Aplastic Anemia
Modified Delphi panel consensus recommendations for management of severe aplastic anemia Aug 2024 Blood Advances Aplastic Anemia
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies Oct 2023 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Towards a Conceptualization of Measurable Residual Disease in Myelodysplastic Syndromes Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients Jun 2019 Blood Advances Myelodysplastic Syndromes (MDS)
Guideline-based indicators for adult patients with myelodysplastic syndromes Aug 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)